Spectrin Breakdown Products (SBDPs) as Potential Biomarkers for Neurodegenerative Diseases.
Spectrin Breakdown Products (SBDPs) as Potential Biomarkers for Neurodegenerative Diseases.
复制标题
DOI：
10.1007/s13670-012-0009-2
复制
发表时间：
2012-06
期刊：
影响因子：
--
通讯作者：
Jeromin, A
中科院分区：
文献类型：
--
作者：
Yan, Xiao-Xin;Jeromin, Andreas;Jeromin, A
The world’s human population ages rapidly thanks to the great advance in modern medicine. While more and more body system diseases become treatable and curable, age-related neurodegenerative diseases remain poorly understood mechanistically, and are desperately in need of preventive and therapeutic interventions. Biomarker development consists of a key part of concerted effort in combating neurodegenerative diseases. In many chronic neurodegenerative conditions, neuronal damage/death occurs long before the onset of disease symptoms, and abnormal proteolysis may either play an active role or be a companying event of neuronal injury. Increased spectrin cleavage yielding elevated spectrin breakdown products (SBDPs) by calcium-sensitive proteases such as calpain and caspases has been established in conditions associated with acute neuronal damage such as traumatic brain injury (TBI). Here we review literature regarding spectrin expression and metabolism in the brain, and propose a potential use of SBDPs as biomarkers for neurodegenerative diseases such as Alzheimer’s diseases.
